Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mirati Therapeutics Inc (NASDAQ:MRTX)

5.45
Delayed Data
As of Aug 21
 -0.15 / -2.68%
Today’s Change
2.70
Today|||52-Week Range
7.22
+14.74%
Year-to-Date

Today’s Trading

Previous close5.60
Today’s open5.60
Day’s range5.30 - 5.65
Volume76,912
Average volume (3 months)199,483
Market cap$139.8M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)-9.95%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.12-5.13%
REPHRecro Pharma Inc-0.27-3.72%
MDWDMediwound Ltd0.000.00%
ADMPAdamis Pharmaceutica...+0.25+5.43%
Data as of 08/21/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$0.00
Annual profit (last year)-$83.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Financial Officer &
Senior Vice President
Jamie A. Donadio
Corporate headquarters
San Diego, California

Forecasts